Unit:
Speciality Clinical NeuropsychologyLibrary of the School of Health Sciences
Author:
Kandylaki Nektaria
Supervisors info:
Ιωάννης Ζαλώνης, Αν. Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Κωνσταντίνος Πόταγας, Αν. Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Σωκράτης Παπαγεωργίου, Αν. Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Original Title:
Financial capacity in Parkinson's disease
Translated title:
Financial capacity in Parkinson's disease
Summary:
The ability to understand and manage one’s personal financial affairs (Financial Capacity) is an interesting and multidimensional topic (field) to study, especially in a disease such as Parkinson’s (PD). After understanding and thoroughly investigating the pathophysiology of the disease and the financial behavior in it, the present study aimed at 1) exploring whether patients on different medication (Levodopa and Dopamine Agonists) exhibited different financial capacity, 2) wheth-er the performance in financial tasks could be predicted by neuropsychiatric symptoms, dementia, specific cognitive deficits in PD or by the time elapses since the diagnosis, and 3) if there is a specific point in the natural progression of PD from when on, financial capacity starts to diminish particularly, making it impossible for patients to manage their financial affairs (financial incapa-ble). Indeed, the results revealed a statistically significant difference between the groups of Levodopa and Agonists, with the former performing better in financial tasks. Results also showed that the scores of the financial tasks could be predicted from the neuropsychiatric symp-toms and the specific cognitive deficits in PD, but not from dementia or the time since diagnosis. The latter was not correlated with the financial tasks and thus the cut-off in time couldn’t be tested for. These results are of great value for the literature and everyday clinical practice. Yet further research is required.
Main subject category:
Health Sciences
Keywords:
Financial capacity, Parkinson’s, Levodopa, Agonists, Treatment, Medication
